Skip to content
Use caution Medical device recall · FDA · Published June 25, 2026

ResMed Astral Ventilators Recall: Supercapacitor Leak Risks Ventilation Failure

ResMed recalls Astral 100/150 and 100/50 ventilators due to supercapacitor electrolyte leakage that may damage charger chips, causing ventilation interruptions. Affected units have specific serial numbers and model codes.

🇺🇸 FDA recall #Z-2735-2026Medical deviceResMed ›
✎ GovInfoNow plain-language explainer

ResMed is recalling its Astral 100/150 and 100/50 ventilators because a supercapacitor electrolyte leak can damage the charger chip, leading to interrupted ventilation therapy. This poses a risk to patients who rely on these devices for breathing support. Read more at govinfonow.com/recall/169207-resmed-astral-ventilators-recall-supercapacitor-leak-risks-ventilation-failure.

Source Summary by GovInfoNow · govinfonow.com/recall/169207-resmed-astral-ventilators-recall-supercapacitor-leak-risks-ventilation-failure · Updated August 17, 2026 · FDA enforcement record: FDA #Z-2735-2026

Cite this page

“ResMed Astral Ventilators Recall: Supercapacitor Leak Risks Ventilation Failure.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/169207-resmed-astral-ventilators-recall-supercapacitor-leak-risks-ventilation-failure. Based on FDA recall #Z-2735-2026 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2735-2026%22&limit=1).

ResMed Ltd. recalled Astral 100/150 and Astral 100/50 ventilator systems worldwide due to potential ventilation interruption caused by a leaking supercapacitor, the FDA said on June 25, 2026. Owners should contact ResMed for repairs.

How to tell if you have it

  • Brand: ResMed
  • Products: Astral 100/150, Astral 100/50
  • Astral 100 Catalog Number: 00619498003259; Serial numbers < 22241890149
  • Astral 150 Catalog Number: 00619498270033; Serial numbers < 22241440282
  • PCBA Spare Parts via physical PCBA or Ventilator UI - Characters 2 8 < 2707658
  • PCBA Spare Parts in Box - Box serial number < 22241978070

The hazard

A leaking supercapacitor electrolyte on the Printed Circuit Board Assembly may damage the charger chip, causing a fail-safe state that interrupts ventilation therapy.

Context

GovInfoNow's records show ResMed Ltd. has issued three other recalls since December 12, 2019. On November 20, 2023, the company recalled AirFit F30 Masks due to magnetic interference risks with medical implants. A September 13, 2023 recall of Astral 100/150 Ventilators addressed sudden power loss during battery issues. Other recent recalls of similar products include Ventec V+Pro Ventilator Recall (March 25, 2026) and Baxter Blue Ventilator Adapter Module Recall (February 18, 2026).

How to tell if you have this one

Check for specific serial numbers: Astral 100/150 units with serial numbers less than 22241890149, and Astral 100/50 units with serial numbers less than 22241440282. Also, verify the PCBA spare parts codes and box serial numbers as listed in the recall notice.

  • Brand
    ResMed
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Device Serial Number

    Identify your ventilator's serial number and compare it to the affected ranges provided in the recall notice.

  2. Contact ResMed

    Reach out to ResMed directly to confirm if your device is affected and receive instructions for next steps.

Where it went and when

Where it was distributed

Distributed nationwide and abroad; the notice names 48 states.

Alaska: named in the noticeAKMaine: named in the noticeMEVermont: named in the noticeVTNew Hampshire: named in the noticeNHWashington: named in the noticeWAIdaho: named in the noticeIDMontana: named in the noticeMTNorth Dakota: named in the noticeNDMinnesota: named in the noticeMNIllinois: named in the noticeILWisconsin: named in the noticeWIMichigan: named in the noticeMINew York: named in the noticeNYRhode Island: named in the noticeRIMassachusetts: named in the noticeMAOregon: named in the noticeORNevada: named in the noticeNVWyoming: named in the noticeWYSouth Dakota: named in the noticeSDIowa: named in the noticeIAIndiana: named in the noticeINOhio: named in the noticeOHPennsylvania: named in the noticePANew Jersey: named in the noticeNJConnecticut: named in the noticeCTCalifornia: named in the noticeCAUtah: named in the noticeUTColorado: named in the noticeCONebraska: named in the noticeNEMissouri: named in the noticeMOKentucky: named in the noticeKYWest Virginia: named in the noticeWVVirginia: named in the noticeVAMaryland: named in the noticeMDDelaware: nationwideDEArizona: named in the noticeAZNew Mexico: named in the noticeNMKansas: named in the noticeKSArkansas: named in the noticeARTennessee: named in the noticeTNNorth Carolina: named in the noticeNCSouth Carolina: named in the noticeSCDistrict of Columbia: named in the noticeDCOklahoma: named in the noticeOKLouisiana: named in the noticeLAMississippi: named in the noticeMSAlabama: named in the noticeALGeorgia: named in the noticeGAHawaii: nationwideHITexas: named in the noticeTXFlorida: named in the noticeFLPuerto Rico: named in the noticePR

FDA distribution: “Worldwide - U.S. Nationwide distribution including in the states of AK, AL, AR, AZ, CA, CO, CT, DC, FL, GA, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, RI, SC, SD, TN, TX,…” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming.

Recall timeline

FDA published this recall 41 days after the firm started it.

1. Firm started the recall: Jun 25, 202612. FDA classified it Class I: Jul 28, 202623. Published in FDA’s Enforcement Report: Aug 5, 202634. Added to GovInfoNow: Aug 11, 202642026
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report
  4. Added to GovInfoNow

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other ResMed recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-2735-2026 (June 25, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-2735-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA